#6
CRISPR Gene Therapy
Following the first approved CRISPR treatment for sickle cell disease, gene editing therapies are entering clinical trials for cancer, blindness, and heart disease.
Photos (1)
Following the first approved CRISPR treatment for sickle cell disease, gene editing therapies are entering clinical trials for cancer, blindness, and heart disease.
Comments on "CRISPR Gene Therapy"
Create a free account or sign in to join the discussion.
Sign in to join the conversation